Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 538,260 | 517,913 | 519,757 | 605,664 | 526,480 |
| Marketable Securities | 194,997 | 164,818 | 121,629 | 118,778 | 104,267 |
| Receivables | 88,216 | 81,393 | 75,688 | 91,637 | 102,083 |
| Inventories | 17,697 | 14,773 | 16,354 | 18,544 | 17,259 |
| TOTAL | $871,671 | $811,016 | $759,730 | $871,929 | $786,287 |
| Non-Current Assets | |||||
| PPE Net | 471,095 | 459,709 | 443,656 | 428,225 | 416,254 |
| Investments And Advances | 326,800 | 350,360 | 393,904 | 266,431 | 268,091 |
| Intangibles | 512,474 | 513,983 | 524,958 | 531,888 | 525,962 |
| Other Non-Current Assets | 205,757 | 195,635 | 187,858 | 164,880 | 162,257 |
| TOTAL | $1,516,126 | $1,519,687 | $1,550,376 | $1,391,424 | $1,372,564 |
| Total Assets | $2,387,797 | $2,330,703 | $2,310,106 | $2,263,353 | $2,158,851 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,062 | 11,541 | 17,544 | 14,762 | 17,632 |
| Accrued Expenses | 179,029 | 169,711 | 169,055 | 174,573 | 158,534 |
| TOTAL | $213,056 | $207,171 | $213,083 | $212,077 | $198,487 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 23,940 | 24,405 | 24,180 | 22,530 | 22,321 |
| Other Non-Current Liabilities | 95,795 | 88,071 | 82,776 | 75,914 | 70,517 |
| TOTAL | $131,583 | $122,874 | $118,288 | $110,956 | $106,316 |
| Total Liabilities | $344,639 | $330,045 | $331,371 | $323,033 | $304,803 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 102,032 | 101,941 | 101,484 | 100,955 | 100,264 |
| Common Shares | 101 | 100 | 101 | 102 | 101 |
| Retained earnings | 2,013,790 | 1,977,478 | 1,938,320 | 1,926,528 | 1,853,602 |
| Other shareholders' equity | -8,192 | -13,355 | -1,718 | -1,690 | 345 |
| TOTAL | $2,043,158 | $2,000,658 | $1,978,735 | $1,940,320 | $1,854,048 |
| Total Liabilities And Equity | $2,387,797 | $2,330,703 | $2,310,106 | $2,263,353 | $2,158,851 |